LNA Sante SA (FR:LNA) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
LNA Santé SA reported a robust first-half performance for 2024, with operating revenue increasing by 5.7% to €386.3 million and operating net result up by 5.1% to €15.0 million, demonstrating the company’s resilience amidst the SMR pricing reform impact. The company also highlighted a solid operating net margin of 3.9% and liquidity of €170 million, which will support future development and health challenges. These results are part of the success of the Grandir Ensemble 3 project and the dedication of their 9,000 professionals to quality care and patient satisfaction.
For further insights into FR:LNA stock, check out TipRanks’ Stock Analysis page.